Milena Vieira Ramos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Milena Vieira Ramos has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Clara Luna Marina
School of Medicine, University of Brasília, UnB, Brasília 70910-900, DF, Brazil
2 shared publications - Cristina Lemos Barbosa Furia
Universidade de Brasília, Brazil
2 shared publications - Diógenes Diego de Carvalho Bispo
Faculty of Medicine, University of Brasília (UNB), Brasília 70910-900, Brazil
2 shared publications - Felipe von Glehn
Faculty of Medicine, University of Brasília (UNB), Brasília 70910-900, Brazil
2 shared publications - Francisco de Assis Mitrovick Pacheco
Hospital Universitário de Brasília, Brasil
2 shared publications - Letícia Dias dos Santos Silva
Research Center for Major Themes—Neurodegenerative Disorders Division, University of Brasília, Brasília 70910-900, Federal District, Brazil
2 shared publications
Latest Publications
- Open Access
- 25 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8246
Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory loss and cognitive decline, which significantly impacts patients’ quality of life and imposes substantial emotional, practical, and economic burdens on their families. As the most common cause of senile dementia, AD currently affects approximately 50 million people worldwide, with projections indicating a threefold increase by 2050 due to rising life expectancy and an aging global population. Diagnosis of AD remains challenging. Neuroimaging techniques reveal atrophy in critical brain regions, particularly in the cortex, hippocampus, and limbic system, which are essential substrates for memory, personality changes, and other cognitive functions. The hallmark molecular changes associated with AD include the accumulation of β-amyloid plaques and the formation of tau protein tangles. Several underlying mechanisms contribute to neuron loss, such as oxidative stress, neuroinflammation, microbial dysbiosis, and insulin resistance. In this context, exosomes—small extracellular vesicles that facilitate cell communication—transport proteins, DNA, mRNA, and non-coding RNA (ncRNA), all of which play a significant role in the neurobiology of AD. Furthermore, emerging research indicates that exosomal ncRNAs may serve as promising biomarkers for AD, offering the possibility of improved diagnostic precision. This review explores the potential of exosomal ncRNAs—specifically circular RNAs and microRNAS—as non-invasive biomarkers for AD, highlighting recent advances and future directions in translational studies.
- 25 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8246
Open AccessExosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory loss and cognitive decline, which significantly impacts patients’ quality of life and imposes substantial emotional, practical, and economic burdens on their families. As the most common cause of senile dementia, AD currently affects approximately 50 million people worldwide, with projections indicating a threefold increase by 2050 due to rising life expectancy and an aging global population. Diagnosis of AD remains challenging. Neuroimaging techniques reveal atrophy in critical brain regions, particularly in the cortex, hippocampus, and limbic system, which are essential substrates for memory, personality changes, and other cognitive functions. The hallmark molecular changes associated with AD include the accumulation of β-amyloid plaques and the formation of tau protein tangles. Several underlying mechanisms contribute to neuron loss, such as oxidative stress, neuroinflammation, microbial dysbiosis, and insulin resistance. In this context, exosomes—small extracellular vesicles that facilitate cell communication—transport proteins, DNA, mRNA, and non-coding RNA (ncRNA), all of which play a significant role in the neurobiology of AD. Furthermore, emerging research indicates that exosomal ncRNAs may serve as promising biomarkers for AD, offering the possibility of improved diagnostic precision. This review explores the potential of exosomal ncRNAs—specifically circular RNAs and microRNAS—as non-invasive biomarkers for AD, highlighting recent advances and future directions in translational studies.
- Open Access
- 15 April 2025
- Published by MDPI AG in Preprints.org
Exosomal Non-coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational Research
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory loss and cognitive decline, which significantly impacts patients' quality of life and imposes substantial emotional, practical, and economic burdens on their families. As the most common cause of senile dementia, AD currently affects approximately 50 million people worldwide, with projections indicating a threefold increase by 2050 due to rising life expectancy and an aging global population. Diagnosis of AD remains challenging. Neuroimaging techniques reveal atrophy in critical brain regions, particularly in the cortex, hippocampus, and limbic system, which are essential substrates for memory, personality changes, and other cognitive functions. The hallmark molecular changes associated with AD include the accumulation of β-amyloid plaques and the formation of tau protein tangles. Several underlying mechanisms contribute to neuron loss, such as oxidative stress, neuroinflammation, microbial dysbiosis and insulin resistance. In this context, exosomes − small extracellular vesicles that facilitate cell communication − transport proteins, DNA, mRNA, and non-coding RNA (ncRNA), all of which play a significant role in the neurobiology of AD. Furthermore, emerging research indicates that exosomal ncRNAs may serve as promising biomarkers for AD, offering the possibility of improved diagnostic precision. This review explores the potential of exossomal ncRNAs as non-invasive biomarkers for AD, focusing on recent advances and future directions in translational studies.
- 15 April 2025
- Published by MDPI AG in Preprints.org
Open AccessExosomal Non-coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational Research
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory loss and cognitive decline, which significantly impacts patients' quality of life and imposes substantial emotional, practical, and economic burdens on their families. As the most common cause of senile dementia, AD currently affects approximately 50 million people worldwide, with projections indicating a threefold increase by 2050 due to rising life expectancy and an aging global population. Diagnosis of AD remains challenging. Neuroimaging techniques reveal atrophy in critical brain regions, particularly in the cortex, hippocampus, and limbic system, which are essential substrates for memory, personality changes, and other cognitive functions. The hallmark molecular changes associated with AD include the accumulation of β-amyloid plaques and the formation of tau protein tangles. Several underlying mechanisms contribute to neuron loss, such as oxidative stress, neuroinflammation, microbial dysbiosis and insulin resistance. In this context, exosomes − small extracellular vesicles that facilitate cell communication − transport proteins, DNA, mRNA, and non-coding RNA (ncRNA), all of which play a significant role in the neurobiology of AD. Furthermore, emerging research indicates that exosomal ncRNAs may serve as promising biomarkers for AD, offering the possibility of improved diagnostic precision. This review explores the potential of exossomal ncRNAs as non-invasive biomarkers for AD, focusing on recent advances and future directions in translational studies.
- Open Access
- 3 February 2025
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 22 (4) , e14130
O efeito nefroprotetor da Curcumina como terapia adjuvante ao uso de Doxorrubicina: uma análise morfológica murina
A lesão renal mediada pela Doxorrubicina (DOX) no tratamento de neoplasias proliferativas é um grande desafio no prognóstico e sobrevida de pacientes com câncer. Assim, esta pesquisa procura demonstrar o efeito nefroprotetor da Curcumina (CUR) na nefropatia induzida pela DOX em um modelo experimental murino. Então, os camundongos machos, adultos, da linhagem Balb/c foram divididos randomicamente em 6 grupos: controle, CUR (100 mg/kg por gavagem), DOX 9 mg/kg (intraperitoneal, i.p). DOX 9 mg/kg mais CUR, DOX 16 mg/kg, DOX 16 mg/kg mais CUR. A nefropatia causada pela DOX já é bem conhecida e prossegue com alterações histológicas como infiltrado inflamatório intersticial, hipertrofia tubular, aumento da deposição de colágeno e espessamento da membrana basal, alargamento do espaço de Bowman e diminuição de células glomerulares. Desse modo, nossa pesquisa demonstra que a Curcumina, um polifenol amarelado extraído da Cúrcuma (Curcuma longa), foi capaz de reduzir a toxicidade do tecido renal causada pela DOX, evidenciada pelo aumento da sobrevida e pela preservação da arquitetura tecidual em análise histopatológica por microscopia óptica com Hematoxilina-Eosina (HE) e Ácido Periódico de Schiff (PAS). Assim, nossos resultados reforçam a evidência do efeito nefroprotetor da CUR como terapia adjuvante ao uso de DOX, porém ainda são necessárias pesquisas futuras com esse enfoque para a melhor compreensão dos mecanismos envolvidos, da segurança e eficácia dessa terapêutica em humanos.
- 3 February 2025
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 22 (4) , e14130
Open AccessO efeito nefroprotetor da Curcumina como terapia adjuvante ao uso de Doxorrubicina: uma análise morfológica murina
A lesão renal mediada pela Doxorrubicina (DOX) no tratamento de neoplasias proliferativas é um grande desafio no prognóstico e sobrevida de pacientes com câncer. Assim, esta pesquisa procura demonstrar o efeito nefroprotetor da Curcumina (CUR) na nefropatia induzida pela DOX em um modelo experimental murino. Então, os camundongos machos, adultos, da linhagem Balb/c foram divididos randomicamente em 6 grupos: controle, CUR (100 mg/kg por gavagem), DOX 9 mg/kg (intraperitoneal, i.p). DOX 9 mg/kg mais CUR, DOX 16 mg/kg, DOX 16 mg/kg mais CUR. A nefropatia causada pela DOX já é bem conhecida e prossegue com alterações histológicas como infiltrado inflamatório intersticial, hipertrofia tubular, aumento da deposição de colágeno e espessamento da membrana basal, alargamento do espaço de Bowman e diminuição de células glomerulares. Desse modo, nossa pesquisa demonstra que a Curcumina, um polifenol amarelado extraído da Cúrcuma (Curcuma longa), foi capaz de reduzir a toxicidade do tecido renal causada pela DOX, evidenciada pelo aumento da sobrevida e pela preservação da arquitetura tecidual em análise histopatológica por microscopia óptica com Hematoxilina-Eosina (HE) e Ácido Periódico de Schiff (PAS). Assim, nossos resultados reforçam a evidência do efeito nefroprotetor da CUR como terapia adjuvante ao uso de DOX, porém ainda são necessárias pesquisas futuras com esse enfoque para a melhor compreensão dos mecanismos envolvidos, da segurança e eficácia dessa terapêutica em humanos.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Audiology - Communication Research
- Vol. 28
Autoavaliação de sintomas relacionados à voz em indivíduos com câncer de tireoide antes, imediatamente após e no pós-operatório tardio de tireoidectomia
RESUMO Objetivo Verificar autopercepção de sintomas vocais, de fadiga vocal e relacionados à tireoidectomia em indivíduos com câncer de tireoide, nos momentos pré-operatório, pós-operatório imediato e pós-operatório tardio, e analisar a influência do gênero. Métodos Trata-se de um estudo de intervenção antes e após com 20 indivíduos com câncer de tireoide, média de 46 anos de idade, avaliados em três momentos: pré-cirurgia (M1), imediatamente após cirurgia (M2) e no pós-operatório tardio (M3) da tireoidectomia. Os indivíduos responderam aos instrumentos Escala de Sintomas Vocais, Índice de Fadiga Vocal e Thyroidectomy-Related Voice and Symptom Questionnaire. Os dados foram analisados de forma descritiva e inferencial. Resultados Na autoavaliação de sintomas vocais físicos e orofaringolaríngeos relacionados à tireoidectomia, o M3 apresentou valores estatisticamente menores que o M1 (p=0,006 e p=0,028, respectivamente) e o M2 (p<0,001 e p=0,004, respectivamente). Para os sintomas totais (p=0,001) e vocais (p=0,001) relacionados à tireoidectomia, os valores do M3 foram significativamente menores que os do M2. Na autoavaliação de sintomas vocais dos domínios total e limitação, o M1 (p<0,001; p<0,001) e o M3 (p=0,013; p=0,001) apresentaram valores significativamente menores que o M2. Indivíduos do gênero masculino apresentaram percepção de sintomas de fadiga no domínio fadiga e limitação vocal (p=0,035) e percepção de sintomas relacionados à tireoidectomia nos domínios total (p=0,044) e sintomas vocais (p=0,012) significativamente menores do que os do gênero feminino, independentemente do momento. Conclusão Sintomas vocais físicos e relacionados à tireoidectomia diminuem no pós-operatório tardio; sintomas vocais totais e limitação aumentam no pós-operatório imediato e diminuem no tardio. Mulheres têm maior percepção de fadiga e limitação vocal e de sintomas totais e vocais relacionados à tireoidectomia.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Audiology - Communication Research
- Vol. 28
Open AccessAutoavaliação de sintomas relacionados à voz em indivíduos com câncer de tireoide antes, imediatamente após e no pós-operatório tardio de tireoidectomia
RESUMO Objetivo Verificar autopercepção de sintomas vocais, de fadiga vocal e relacionados à tireoidectomia em indivíduos com câncer de tireoide, nos momentos pré-operatório, pós-operatório imediato e pós-operatório tardio, e analisar a influência do gênero. Métodos Trata-se de um estudo de intervenção antes e após com 20 indivíduos com câncer de tireoide, média de 46 anos de idade, avaliados em três momentos: pré-cirurgia (M1), imediatamente após cirurgia (M2) e no pós-operatório tardio (M3) da tireoidectomia. Os indivíduos responderam aos instrumentos Escala de Sintomas Vocais, Índice de Fadiga Vocal e Thyroidectomy-Related Voice and Symptom Questionnaire. Os dados foram analisados de forma descritiva e inferencial. Resultados Na autoavaliação de sintomas vocais físicos e orofaringolaríngeos relacionados à tireoidectomia, o M3 apresentou valores estatisticamente menores que o M1 (p=0,006 e p=0,028, respectivamente) e o M2 (p<0,001 e p=0,004, respectivamente). Para os sintomas totais (p=0,001) e vocais (p=0,001) relacionados à tireoidectomia, os valores do M3 foram significativamente menores que os do M2. Na autoavaliação de sintomas vocais dos domínios total e limitação, o M1 (p<0,001; p<0,001) e o M3 (p=0,013; p=0,001) apresentaram valores significativamente menores que o M2. Indivíduos do gênero masculino apresentaram percepção de sintomas de fadiga no domínio fadiga e limitação vocal (p=0,035) e percepção de sintomas relacionados à tireoidectomia nos domínios total (p=0,044) e sintomas vocais (p=0,012) significativamente menores do que os do gênero feminino, independentemente do momento. Conclusão Sintomas vocais físicos e relacionados à tireoidectomia diminuem no pós-operatório tardio; sintomas vocais totais e limitação aumentam no pós-operatório imediato e diminuem no tardio. Mulheres têm maior percepção de fadiga e limitação vocal e de sintomas totais e vocais relacionados à tireoidectomia.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Audiology - Communication Research
- Vol. 28
Self-assessment of voice-related symptoms in individuals with thyroid cancer before, immediately after, and in the late postoperative period of thyroidectomy
Purpose To verify the self-perception of symptoms and vocal fatigue related to thyroidectomy in individuals with thyroid cancer in the pre, immediate post and late post-operative moments, and to analyze the influence of gender. Methods Intervention study before and after with 20 individuals, mean age 46 years, evaluated before surgery (M1), immediately after surgery (M2) and in the late postoperative period (M3) of thyroidectomy. Individuals answered the instruments: Voice Symptoms Scale, Vocal Fatigue Index and Thyroidectomy-Related Voice and Symptom Questionnaire. Data were analyzed descriptively and inferentially. Results In self-assessment of vocal symptoms of the total domains and limitation, M1 (p<0.001; p<0.001, respectively) and M3 (p=0.013; p=0.001, respectively) had significantly lower values than the M2. For the physical domain of self-assessment of vocal symptoms, the M3 showed statistically lower values than the M1 (p=0.006) and the M2 (p<0.001) assessments. Depending on the moment, the oropharyngolaryngeal symptoms in M3 had significantly lower values than M2 (p=0.004) and M1 (p=0.028). Male scores were significantly lower than female scores in the self-assessment of fatigue symptoms in the fatigue and vocal limitation domain (p=0.035), regardless of the time of assessment. Conclusion Physical vocal symptoms and thyroidectomy-related symptoms decrease in the late postoperative period; total vocal symptoms and limitation increasing in the immediate postoperative period and decrease in the late postoperative period. Women have a higher perception of vocal fatigue and limitation, and of total and vocal symptoms related to thyroidectomy.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Audiology - Communication Research
- Vol. 28
Open AccessSelf-assessment of voice-related symptoms in individuals with thyroid cancer before, immediately after, and in the late postoperative period of thyroidectomy
Purpose To verify the self-perception of symptoms and vocal fatigue related to thyroidectomy in individuals with thyroid cancer in the pre, immediate post and late post-operative moments, and to analyze the influence of gender. Methods Intervention study before and after with 20 individuals, mean age 46 years, evaluated before surgery (M1), immediately after surgery (M2) and in the late postoperative period (M3) of thyroidectomy. Individuals answered the instruments: Voice Symptoms Scale, Vocal Fatigue Index and Thyroidectomy-Related Voice and Symptom Questionnaire. Data were analyzed descriptively and inferentially. Results In self-assessment of vocal symptoms of the total domains and limitation, M1 (p<0.001; p<0.001, respectively) and M3 (p=0.013; p=0.001, respectively) had significantly lower values than the M2. For the physical domain of self-assessment of vocal symptoms, the M3 showed statistically lower values than the M1 (p=0.006) and the M2 (p<0.001) assessments. Depending on the moment, the oropharyngolaryngeal symptoms in M3 had significantly lower values than M2 (p=0.004) and M1 (p=0.028). Male scores were significantly lower than female scores in the self-assessment of fatigue symptoms in the fatigue and vocal limitation domain (p=0.035), regardless of the time of assessment. Conclusion Physical vocal symptoms and thyroidectomy-related symptoms decrease in the late postoperative period; total vocal symptoms and limitation increasing in the immediate postoperative period and decrease in the late postoperative period. Women have a higher perception of vocal fatigue and limitation, and of total and vocal symptoms related to thyroidectomy.